Skip to content

Wills Financial Group, Inc.: AMD position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Wills Financial Group, Inc. on AMD, newest first. How the timeline and the estimate are built.

Wills Financial Group, Inc. held 0 AMD shares at 2024-03-31 per its 13F-HR filed 2024-05-09.

the latest 13F is the newest step

  1. period ended2024-03-31
    13F 0 shares
    Change vs previous 13F -11,108 shares

    13F-HR 0001525109-24-000002 filed by Wills Financial Group, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2023-12-31
    13F 11,108 shares
    Change vs previous 13F -2,016 shares

    0.83% of the 13F portfolio, value $1,637,430.

    13F-HR 0001525109-24-000001 filed by Wills Financial Group, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2023-09-30
    13F 13,124 shares
    Change vs previous 13F +1,939 shares

    0.73% of the 13F portfolio, value $1,349,410.

    13F-HR 0001525109-23-000005 filed by Wills Financial Group, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2023-06-30
    13F 11,185 shares
    Change vs previous 13F -270 shares

    0.65% of the 13F portfolio, value $1,274,083.

    13F-HR 0001525109-23-000004 filed by Wills Financial Group, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2023-03-31
    13F 11,455 shares
    Change vs previous 13F not available

    0.6% of the 13F portfolio, value $1,122,705.

    13F-HR 0001525109-23-000003 filed by Wills Financial Group, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).